Lexington, Mass., June 21, 2021 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, today announced the launch of the Persona RF PREMIUM in the United States. The Persona RF PREMIUM is an innovative radiography and fluoroscopy system designed for hospitals and medical centers of all sizes, providing real-time imaging for skeletal, digestive, urinary, respiratory, reproductive systems; and specific organs including the heart, lung and kidneys.

“Today's high patient volumes call for a simple, yet highly advanced multi-purpose radiographic fluoroscopy system,” Hidetoshi Izawa, vice president of Modality Solutions, Clinical Affairs, and In-Vitro Diagnostics, FUJIFILM Medical Systems U.S.A., Inc. “With the Persona RF PREMIUM system, medical facilities both large and small can expect an excellent return on their investment with the system’s combination of low dose, optimal image quality, ease-of-use and exam versatility. Fujifilm is proud to expand our cutting-edge medical imaging portfolio to provide hospitals with the technologies they need to positively impact patient care."

Competitive clinical capabilities designed to improve patient comfort include the system’s ability to support patients of up to 584 pounds without any table movement restrictions, and easily adapts for mobility reduced patients. Productivity-enhancing capabilities offered by the Persona RF PREMIUM include an integrated video camera in the collimator, providing the ability to position the patient without using fluoroscopy, and a workstation software that is linked to the table to provide quick automatic positioning, freeing up valuable time for the patient.
The Persona RF PREMIUM is available for purchase in the U.S.


About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It’s ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse® Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujifilmhealthcare.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.

X-Ray Homepage